SCHEMBL7780707

SCHEMBL7780707

CS(=O)(=O)c1ccc(-c2n[nH]cc2-c2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.53
PTGS1 P23219 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780688 0.86 MAOA (0.52) PTGS2PTGS1
SCHEMBL7779346 0.86 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL7779428 0.86 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL7780024 0.85 PTGS2 (0.62) PTGS2PTGS1
SCHEMBL7777544 0.84 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL7779700 0.84 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL7779383 0.82 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL7772991 0.82 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL7777637 0.82 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL7780899 0.81 PTGS2 (0.62) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed